-+ 0.00%
-+ 0.00%
-+ 0.00%

VolitionRx Participates in Launch of DETECSEPS Program in France

Barchart·09/17/2026 07:17:00
Listen to the news

French Government-Funded €6.3 million (~$7.3 million) Consortium Selects Volition's Nu.Q® NETs Assay as Sole Biomarker for France's Real World Evaluation of Early Detection of Sepsis

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.